Clinical trial
Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression
NCT05712967 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 14, 2019
- Completion date
- February 5, 2024
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.